Position in ZTS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,104,057
-$1,309,081 QoQ
Shares Held
15,364
-24.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#618
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $7,864,240 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
36,937 | $4,097,790 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
15,364 | $1,104,057 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,521 | $824,123 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,680 | $666,758 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
3,512 | $591,912 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
40,000 | $579,600 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,104,057 | 15,364 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,413,138 | 20,414 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,291,433 | 18,212 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,664,779 | 18,212 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,840,161 | 18,212 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,317,697 | 20,150 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,380,797 | 20,750 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,634,068 | 18,600 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $3,397,856 | 19,600 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,164,227 | 18,700 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,572,397 | 18,100 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,688,376 | 21,200 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $3,650,852 | 21,200 | Shares | Sole | 2024-04-05 | |
| 2023-03-31 | $3,428,664 | 20,600 | Shares | Sole | 2024-04-05 | |
| 2022-12-31 | $2,887,035 | 19,700 | Shares | Sole | 2024-04-05 | |
| 2022-09-30 | $3,128,919 | 21,100 | Shares | Sole | 2024-04-05 | |
| 2022-06-30 | $3,626,879 | 21,100 | Shares | Sole | 2024-04-05 | |
| 2022-03-31 | $3,998,108 | 21,200 | Shares | Sole | 2024-04-05 | |
| 2021-12-31 | $5,685,899 | 23,300 | Shares | Sole | 2024-04-05 | |
| 2021-09-30 | $4,193,424 | 21,600 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $3,745,836 | 20,100 | Shares | Sole | 2024-04-05 | |
| 2021-03-31 | $3,086,608 | 19,600 | Shares | Sole | 2024-04-05 | |
| 2020-12-31 | $3,525,150 | 21,300 | Shares | Sole | 2024-04-05 | |
| 2020-09-30 | $1,785,996 | 10,800 | Shares | Sole | 2024-04-05 | |
| 2020-06-30 | $1,480,032 | 10,800 | Shares | Sole | 2024-04-05 | |
| 2020-03-31 | $1,271,052 | 10,800 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||